Diagnosis of cure in cushing's syndrome: Lessons from long-term follow-up

Frontiers of Hormone Research

Volumn 38, Issue , 2010, Pages 152-157

  Barahona, M J ^a   Resmini, E ^a   Sucunza, N ^a   Webb, S M ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

BODY COMPOSITION; BODY FAT; BONE MASS; CARDIOVASCULAR RISK; COHORT ANALYSIS; CUSHING SYNDROME; FOLLOW UP; HUMAN; HYPERCORTISOLISM; LEAN BODY WEIGHT; METABOLIC PARAMETERS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW;

ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; CUSHING SYNDROME; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MORBIDITY; QUALITY OF LIFE;

EID: 84926106781     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000318505     Document Type: Review

References (12)

1. Etxabe J, Vázquez JA: Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol 1994;40:479-484.
2. Ambrosi B, Sartorio A, Pizzocaro A, Passini E, Bottasso B: Evaluation of haemostatic and fibrin-olytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma. Exp Clin Endocrinol Diabetes 2000;108:294-298.
3. Cavagnini F, Pecori-Giraldi F: Epidemiology and follow-up of Cushing's disease. Ann Med 2001;62: 168-172.
4. Rees DA Hanna F W, Davies JS, Mills RG, Vafidis J, Scanlon: Long-term follow-up results of transsphe-noidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol 2002;56:541-551.
5. Swearingen B, Biller BMK, Barker FG, Katznelson L, Grinspoon S, Klibanski A, Zervas NT: Long-term mortality after transsphenoidal surgery for Cushing's disease. Ann Intern Med 1999;245:821-824.
6. Pikkarainen L, Sane T, Reunanen A: The survival and well-being of patients treated for Cushing's syndrome. J Intern Med 1999;245:463-468.
7. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G: Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 1999;84:2664-2672.
8. Van Aken MO, Pereira AM, Biermasz NR, van Thiel S W, Hoftijzer HC, Smit J W, Roelfsema F, Lamberts S W, Romijn JA: Quality of life in patients after long-term biochemical cure of Cushing's disease. J Clin Endocrinol Metab 2005;90:3279-3786.
9. Webb SM, Badia X, Barahona MJ, Colao A, Stras-burger CJ, Tabarin A, van Aken MO, Pivonello R, Stalla G, Lamberts SWJ, Glusman JE: Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire (CushingQoL). Eur J Endocrinol 2008;158:623-630.
10. Barahona MJ, Sucunza N, Resmini E, Fernández-Real JM, Ricard W, Moreno JM, Puig T, Farrerons J, Webb S: Persistent increase in body fat mass and inflammation despite long-term cured Cushings syndrome. J Clin Endocrinol Metab 2009;94:3365-3371.
11. Lindsay JR, Nansel T, Baid S, Gumowski J, Nieman LK: Long-term impaired quality of life in Cushing's syndrome despite initial improvement after surgical remission. J Clin Endocrinol Metab 2006;91:447-453.
12. Lindholm J, Juul S, Jorgensen JO, Astrup J, Bjerre P, Feldt-Rasmussen U, Hagen C, Jorgensen J, Kostel-janetz M, Kristensen L, Laurberg P, Schmidt K, Weeke J: Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endo-crinol Metab 2001;86:117-123.